These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide. Inoue K, Hisatomi A, Umeda F, Nawata H. Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552 [Abstract] [Full Text] [Related]
32. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related]
35. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE. Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831 [Abstract] [Full Text] [Related]
37. Pancreatic amylin content in human diabetic subjects and its relation to diabetes. Tasaka Y, Nakaya F, Matsumoto H, Iwamoto Y, Omori Y. Pancreas; 1995 Oct; 11(3):303-8. PubMed ID: 8577686 [Abstract] [Full Text] [Related]
38. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhäusl W, Pacini G, Prager R. Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800 [Abstract] [Full Text] [Related]